Scholars Central

ArticlePublished 30 Mar 2023

Recombinant Protein Bioprocessing

Authors: Bonnie David

Pharmaceutical Bioprocessing

Volume 11 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recombinant protein synthesis is essential for both the discovery of novel protein therapeutics and the structural identification of pharmacological targets. Recombinant protein manufacturing therefore plays a significant part in the creation of pharmaceuticals. Around 30% of the biopharmaceuticals now available on the market are produced using recombinant proteins that are frequently produced on bacterial hosts. I outline key ideas in this review related to the creation of drugs and production scales for recombinant proteins in bacteria. How can this failure be minimised to quickly give maximal quantities of high-quality protein and so speed up drug discovery? Recombinant protein manufacturing systems frequently experience failure.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutical Bioprocessing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Bioprocessing
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Bonnie David”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels